> top > docs > PubMed:33331603 > annotations

PubMed:33331603 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
1 44-52 Disease denotes COVID-19 MESH:C000657245
8 279-296 Disease denotes flu-like syndrome MESH:D007251
9 370-378 Disease denotes COVID-19 MESH:C000657245
10 439-456 Disease denotes flu-like syndrome MESH:D007251
11 485-493 Disease denotes COVID-19 MESH:C000657245
12 932-938 Species denotes people Tax:9606
13 1239-1247 Disease denotes COVID-19 MESH:C000657245

ENG_RE_CONSENSUS

Id Subject Object Predicate Lexical cue
T0 288-296 DOID_225 denotes syndrome
T1 336-353 HP_0003674 denotes onset of symptoms
T10 370-378 HP_0033141 denotes COVID-19
T2 370-378 DOID_0080600 denotes COVID-19
T3 448-456 DOID_225 denotes syndrome
T11 485-493 HP_0033141 denotes COVID-19
T4 485-493 DOID_0080600 denotes COVID-19
T5 669-682 HP_0003674 denotes symptom onset
T6 846-859 HP_0003674 denotes symptom onset
T7 1103-1110 CHEBI_59132 denotes antigen
T8 1198-1211 HP_0003674 denotes symptom onset
T12 1239-1247 HP_0033141 denotes COVID-19
T9 1239-1247 DOID_0080600 denotes COVID-19
R0 T0 T7 effect syndrome,antigen
R1 T2 T7 effect COVID-19,antigen
R2 T3 T7 effect syndrome,antigen
R3 T9 T7 effect COVID-19,antigen

ENG_NER_NEL_CONSENSUS

Id Subject Object Predicate Lexical cue
T1 288-296 DOID:225 denotes syndrome
T10 448-456 DOID:225 denotes syndrome
T11 448-456 MESH:D013577 denotes syndrome
T12 485-493 DOID:0080600 denotes COVID-19
T16 647-651 MESH:D013995 denotes time
T18 669-682 HP:0003674 denotes symptom onset
T2 288-296 MESH:D013577 denotes syndrome
T21 833-837 MESH:D013995 denotes time
T23 846-859 HP:0003674 denotes symptom onset
T24 939-943 MESH:D000368 denotes aged
T26 993-999 MESH:D001938 denotes Brazil
T29 1077-1081 MESH:D013995 denotes time
T30 1103-1110 CHEBI:59132 denotes antigen
T34 1151-1155 MESH:D013995 denotes time
T36 1198-1211 HP:0003674 denotes symptom onset
T38 1216-1220 MESH:D013995 denotes time
T4 314-318 MESH:D013995 denotes time
T40 370-378 MESH:D000086382 denotes COVID-19
T41 485-493 MESH:D000086382 denotes COVID-19
T43 1097-1116 MESH:D000086742 denotes rapid antigen tests
T44 370-378 HP:0033141 denotes COVID-19
T45 485-493 HP:0033141 denotes COVID-19
T47 1230-1247 MESH:D000086742 denotes test for COVID-19
T5 336-353 HP:0003674 denotes onset of symptoms
T6 370-378 DOID:0080600 denotes COVID-19
T9 428-435 MESH:D011996 denotes records

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T1 0-102 Sentence denotes Time interval between onset of symptoms and COVID-19 testing in Brazilian state capitals, August 2020.
T2 103-239 Sentence denotes Intervalo de tempo decorrido entre o início dos sintomas e a realização do exame para COVID-19 nas capitais brasileiras, agosto de 2020.
T3 240-250 Sentence denotes OBJECTIVE:
T4 251-379 Sentence denotes To analyze notifications of flu-like syndrome according to the time interval between onset of symptoms and testing for COVID-19.
T5 380-388 Sentence denotes METHODS:
T6 389-642 Sentence denotes This was a cross-sectional study using records of flu-like syndrome cases containing results of COVID-19 diagnostic tests in the Brazilian state capitals and Federal District, held on the e-SUS Notifica system, from March 1st, 2020 to August 18th, 2020.
T7 643-783 Sentence denotes The time interval between symptom onset and testing was compared using the ANOVA test, classifying it according to test adequacy/timeliness.
T8 784-792 Sentence denotes RESULTS:
T9 793-894 Sentence denotes Taking 1,942,514 notifications, average time between symptom onset and testing was 10.2 days (±17.1).
T10 895-1021 Sentence denotes Among those tested, females (55.1%), people aged 20-39 years (43.8%), and the Southeast region of Brazil (43.0%) predominated.
T11 1022-1156 Sentence denotes 58.8% of IgM ELISA tests were performed at an adequate time while 68.0% of rapid antigen tests were not performed at an adequate time.
T12 1157-1168 Sentence denotes CONCLUSION:
T13 1169-1273 Sentence denotes Inadequacy was found between symptom onset and time taken to test for COVID-19 in the Brazilian regions.